Response-adaptive dose-finding under model uncertainty
From MaRDI portal
Publication:641106
Abstract: Dose-finding studies are frequently conducted to evaluate the effect of different doses or concentration levels of a compound on a response of interest. Applications include the investigation of a new medicinal drug, a herbicide or fertilizer, a molecular entity, an environmental toxin, or an industrial chemical. In pharmaceutical drug development, dose-finding studies are of critical importance because of regulatory requirements that marketed doses are safe and provide clinically relevant efficacy. Motivated by a dose-finding study in moderate persistent asthma, we propose response-adaptive designs addressing two major challenges in dose-finding studies: uncertainty about the dose-response models and large variability in parameter estimates. To allocate new cohorts of patients in an ongoing study, we use optimal designs that are robust under model uncertainty. In addition, we use a Bayesian shrinkage approach to stabilize the parameter estimates over the successive interim analyses used in the adaptations. This approach allows us to calculate updated parameter estimates and model probabilities that can then be used to calculate the optimal design for subsequent cohorts. The resulting designs are hence robust with respect to model misspecification and additionally can efficiently adapt to the information accrued in an ongoing study. We focus on adaptive designs for estimating the minimum effective dose, although alternative optimality criteria or mixtures thereof could be used, enabling the design to address multiple objectives.
Recommendations
- Optimal designs for dose-finding studies
- Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
- Robust designs for dose-response studies: model and labelling robustness
- Dose Finding – A Challenge in Statistics
- Adaptive designs for dose-finding based on efficacy-toxicity response
Cites work
- scientific article; zbMATH DE number 4143280 (Why is no real title available?)
- scientific article; zbMATH DE number 46726 (Why is no real title available?)
- scientific article; zbMATH DE number 3502650 (Why is no real title available?)
- scientific article; zbMATH DE number 700041 (Why is no real title available?)
- scientific article; zbMATH DE number 720675 (Why is no real title available?)
- scientific article; zbMATH DE number 720676 (Why is no real title available?)
- scientific article; zbMATH DE number 735224 (Why is no real title available?)
- scientific article; zbMATH DE number 1048003 (Why is no real title available?)
- scientific article; zbMATH DE number 1865509 (Why is no real title available?)
- scientific article; zbMATH DE number 800961 (Why is no real title available?)
- A Bayesian A ‐Optimal and Model Robust Design Criterion
- Asymptotic Statistics
- Bayes Factors
- Bayesian experimental design: A review
- Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies
- Econometrics.
- Experimental design in a class of models
- MULTIPLE-OBJECTIVE DESIGNS IN A DOSE-RESPONSE EXPERIMENT
- On the Equivalence of Constrained and Compound Optimal Designs
- Optimal designs for dose-finding studies
- Optimal designs for the emax, log-linear and exponential models
- Optimal designs for the power logistic model
- Optimal discrimination designs
- Optimum experimental designs, with SAS
- Separable nonlinear least squares: the variable projection method and its applications
- Some robust design strategies for percentile estimation in binary response models
- The Intrinsic Bayes Factor for Model Selection and Prediction
Cited in
(18)- Optimal adaptive allocation using deep reinforcement learning in a dose-response study
- cLRT-Mod: an efficient methodology for pharmacometric model-based analysis of longitudinal phase II dose finding studies under model uncertainty
- A new approach towards minimizing the risk of misdosing warfarin initiation doses
- A robust treatment of a dose–response study
- Model selection characteristics when using MCP‐Mod for dose–response gene expression data
- BMA‐Mod: A Bayesian model averaging strategy for determining dose‐response relationships in the presence of model uncertainty
- A Review of Modern Computational Algorithms for Bayesian Optimal Design
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates
- Statistical considerations in model-based dose finding for binary responses under model uncertainty
- On optimal designs for clinical trials: an updated review
- Bayesian learning of dose-response parameters from a cohort under response-guided dosing
- Dose response signal detection under model uncertainty
- Adaptive dose‐response studies to establish proof‐of‐concept in learning‐phase clinical trials
- Robust response-guided dosing
- Adaptive Bayesian compound designs for dose finding studies
- Generalized multiple contrast tests in dose-response studies
- Model-robust Bayesian design through generalised additive models for monitoring submerged shoals
- Optimal designs for dose-finding studies
This page was built for publication: Response-adaptive dose-finding under model uncertainty
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q641106)
